Strides Pharma Science Ltd

Announcement under Regulation 30 (LODR)-Press Release / Media Release

03:04 PM, 30th Apr 2025

Strides strengthens Anti-Inflammatory Portfolio with USFDA approval for Celecoxib Capsules 100 mg 200 mg and 400 mg